PRAME and melanoma: The use of immunohistochemistry for detecting the expression of the preferentially expressed in melanoma antigen (PRAME), a tumor-associated antigen expressed, among others, by melanoma, myxoid liposarcoma, and synovial sarcoma [83], has shown some clinical value in the differential diagnosis of spitzoid lesions.